Author: Kristen Smith|| Date Published: June 23, 2025
STERIS has secured a $450 million contract modification from the Defense Logistics Agency to provide patient monitoring and capital equipment for the U.S. Army, Navy, Air Force and Marine Corps, and federal civilian agencies.
DLA exercised the five-year option period under a five-year base contract it previously awarded to STERIS, the Department of Defense said Friday.
The company received the base contract, worth $225 million, in June 2020, beating out 40 other bidders.
The modification is a fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract, with the ordering period ending on June 22, 2030.
About STERIS
STERIS, based in Ohio, is a provider of products and services that support patient care with an emphasis on infection prevention. It was previously known as Innovative Medical Technologies.
The Army Contracting Command-Aberdeen Proving Ground and the Capability Program Executive Enterprise Software and Service, formerly Program Executive Office Enterprise,…
LMI has been awarded a $100 million Small Business Innovation Research Phase III indefinite-delivery/indefinite-quantity contract to support life cycle logistics and…
Melissa Bischoping, senior director of security and product design research at Tanium, said adopting agentic artificial intelligence and other autonomous…
